First clinical trial using CRISPR approved by National Institutes of Health advisory panel
June 28 2016
Pushing cells against cancer A proposal for the first clinical trial involving CRISPR-Cas9 gene editing has been approved by the National Institutes of Health Recombinant DNA Advisory Committee. The Phase I trial, which will require approval from the Food and Drug Administration, is designed to test the safety of using CRISPR gene editing to modify
